{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000059","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.832970+00:00","generated_at":"2026-06-02T08:23:53.851329+00:00","sec_items":["1.01","5.08","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Lifecore gets $5.5M prepayment from Alcon; annual meeting set for Aug 15, 2024","bullets":["Alcon Research paid $5.5M prepayment for future product purchases; credits apply in 2026.","Lifecore subsidiary amends contract manufacturing agreement with Alcon, effective May 2, 2024.","Board sets 2023 annual meeting for Aug 15, 2024; shareholder proposals due by May 18, 2024.","Prepayment provides $5.5M near-term liquidity; customer commitment indicator."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000059","json":"https://secwatch.observer/filing/0001005286-24-000059.json","markdown":"https://secwatch.observer/filing/0001005286-24-000059.md","text":"https://secwatch.observer/filing/0001005286-24-000059.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/0001005286-24-000059-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/lndc-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T08:23:53.851329+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5006d6a8af20eb25eceb014f9ae489e60a47edd0","claim":"LIFECORE BIOMEDICAL, INC. DE amended Amendment No. 1 with Alcon Research, LLC valued at $5,500,000 (effective 2024-05-02).","evidence_excerpt":"On May 2, 2024, Lifecore Biomedical, LLC, a subsidiary of Lifecore Biomedical, Inc. (the “Company”), entered into Amendment No. 1 (the “ARCMA Amendment”) to Amended and Restated Contract Manufacturing Agreement with Alcon Research, LLC (the “ARCMA”), under which Alcon made a prepayment in the amount of $5,500,000 toward future purchases of products under the ARCMA.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000059/0001005286-24-000059-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"supply"},{"label":"Counterparty","value":"Alcon Research, LLC"},{"label":"Value","value":"$5,500,000"},{"label":"Effective","value":"2024-05-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}